journal article·2018-11-12Open access

miR-219a-5p represses migration and invasion of osteosarcoma cells via targeting EYA2

Xitian Zhu, Lei Chen, Jianhua Lin

Abstract

EYA2 is the developmental transcription factor and phosphatase, playing an important role in numerous species in regulating cell death and differentiation. Recent studies showed that EYA2 is dysregulated and involved in the progression of various cancers. However, the expression and role of EYA2 in osteosarcoma remains unclear. Here, we found that EYA2 expression was evidently upregulated osteosarcoma (OS) tissue and cell lines. Next, we predicted EYA2-targeting miRNAs, which was further evaluated using a dual luciferase reporter assay. We found that miR-219a-5p significantly repressed EYA2 expression via binding to the 3'-UTR of EYA2. Furthermore, overexpressed miR-219a-5p significantly repressed OS cell invasion and migration, which was reversed by overexpressed EYA2. While silenced miR-219a-5p induced OS cell invasion and migration, which was reversed by silenced EYA2. In conclusion, our study revealed that miR-219a-5p function as tumour suppressor regulates OS cell invasiveness by repressing EYA2 expression.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Hippo pathway signaling and YAP/TAZ · Developmental Biology and Gene Regulation · RNA Research and Splicing

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Orthopaedic, The First Affiliated Hospital of Fujian Medical University

References (28)

Show source-provided references
1. 10.1038/s41467-018-04530-z10.1038/s41467-018-04530-z ↗
2. Wang Y. Long noncoding RNA DANCR, working as a competitive endogenous RNA, promotes ROCK1-mediated proliferation and metastasis via decoying of miR-335-5p and miR-1972 in osteosarcoma. J Pineal Res. 2018;17:89.
3. 10.1016/j.ydbio.2006.08.05910.1016/j.ydbio.2006.08.059 ↗
4. 10.1146/annurev.biochem.76.052705.16491610.1146/annurev.biochem.76.052705.164916 ↗
5. 10.1038/nature0784910.1038/nature07849 ↗
6. 10.1074/jbc.C90003220010.1074/jbc.C900032200 ↗
7. 10.18632/oncotarget.184210.18632/oncotarget.1842 ↗
8. 10.18632/oncotarget.2286010.18632/oncotarget.22860 ↗
9. 10.1093/abbs/gmv13910.1093/abbs/gmv139 ↗
10. 10.1038/cddis.2017.32510.1038/cddis.2017.325 ↗
11. 10.3892/ijmm.2017.313210.3892/ijmm.2017.3132 ↗
12. 10.1128/MCB.00585-1610.1128/MCB.00585-16 ↗
13. 10.1002/gcc.2200610.1002/gcc.22006 ↗
14. Zhang Y, Ren S, Yuan F, et al. miR-135 promotes proliferation and stemness of oesophageal squamous cell carcinoma by targeting RERG. Artif Cells Nanomed Biotechnol. 2018;2:1–10.
15. 10.1080/21691401.2017.141591810.1080/21691401.2017.1415918 ↗
16. 10.1073/pnas.170302911510.1073/pnas.1703029115 ↗
17. Mari L, Hoefnagel SJM, Zito D, et al. microRNA 125a regulates MHC-I expression on esophageal adenocarcinoma cells, associated with suppression of anti-tumor immune response and poor outcomes of patients. Gastroenterology. 2018;34640–34647: S0016-5085.
18. 10.1002/1878-0261.1235210.1002/1878-0261.12352 ↗
19. 10.1016/j.ymthe.2018.03.00910.1016/j.ymthe.2018.03.009 ↗
20. Wu G, Yu W, Zhang M, et al. MicroRNA-145-3p suppresses proliferation and promotes apotosis and autophagy of osteosarcoma cell by targeting HDAC4. Artif Cells Nanomed Biotechnol. 2018;1:8.
21. Jiashi W, Chuang Q, Zhenjun Z, et al. MicroRNA-506-3p inhibits osteosarcoma cell proliferation and metastasis by suppressing RAB3D expression. Cell Death Dis. 2018;10:1294–1305.
22. 10.1016/j.bbrc.2014.01.17410.1016/j.bbrc.2014.01.174 ↗
23. 10.1097/WNR.0b013e3280148e8b10.1097/WNR.0b013e3280148e8b ↗
24. 10.1016/j.neuron.2010.01.02710.1016/j.neuron.2010.01.027 ↗
25. 10.1016/j.neuron.2010.02.01810.1016/j.neuron.2010.02.018 ↗
26. 10.3892/ijmm.2014.174910.3892/ijmm.2014.1749 ↗
27. 10.1093/abbs/gmx11410.1093/abbs/gmx114 ↗
28. 10.1371/journal.pone.006316410.1371/journal.pone.0063164 ↗